Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
9m agoDICK'S Sporting Goods Introduces Coach by DICK'S, an Agentic AI Conversational Experience to Support Athletes at Every Stage
14m agoTessellis S p A : THE BOARD OF DIRECTORS ACCEPTS DHH S.P.A. OFFER FOR THE ACQUISITION OF PERIMETER B.1
18m agoCleveland-Cliffs Awarded 2025 GM Supplier of the Year by General Motors
23m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
24m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
Imagion Biosystems Ltd. logo

Imagion Biosystems Ltd.

About

0.02AUD+0.00 +15.38%
Closed • Updated at 17:26 GMT+00:00
Market Cap$4.56M
Volume806.8K
Beta0.82
RSI45.30
Health TechnologyMedical Specialties

Imagion Biosystems Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Appendix 4C and Quarterly Activities Report - March 2026
Feb 27 2026
FY25 Appendix 4E and Annual Report
Feb 3 2026
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
Feb 2 2026
IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial
Jan 29 2026
Appendix 4C and Quarterly Activities Report - December 2025

Community Chat

Ask AI

6ix6ixAIEvents